⌘K

Login Start Free

Home/Filings/4/0001213900-22-019688

4//SEC Filing

ADAMS ERIC A 4

Accession 0001213900-22-019688

CIK 0001728328other

View on SEC.gov Company Profile

Filed

Apr 12, 8:00 PM ET

Accepted

Apr 13, 9:43 PM ET

Size

4.5 KB

Accession

0001213900-22-019688

Insider Transaction Report

Form 4

Period: 2022-04-13

InMed Pharmaceuticals Inc.INM

DirectorCEO & President10% Owner

Transactions

Purchase
Common Stock
2022-04-13$0.85/sh+8,560$7,276→ 44,843 total

Documents

1 file

4
ownership.xmlPrimary

Issuer

InMed Pharmaceuticals Inc.

CIK 0001728328

Entity typeother

Related Parties

1

filerCIK 0001817882

Filing Metadata

Form type: 4
Filed: Apr 12, 8:00 PM ET
Accepted: Apr 13, 9:43 PM ET
Size: 4.5 KB

View on SEC.gov